Jiangsu Nhwa Pharmaceutical Co., LTD (SHE:002262)
China · Delayed Price · Currency is CNY 21.61
+0.41 (1.93%)
Oct 30, 2026, 3:04 PM CST
SHE:002262 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 1,257 | 1,450 | 1,416 | 2,159 | 1,532 | 1,608 |
Trading Asset Securities | 2,912 | 2,569 | 2,373 | 1,335 | 1,452 | 1,058 |
Cash & Short-Term Investments | 4,169 | 4,019 | 3,789 | 3,494 | 2,984 | 2,666 |
Cash Growth | 5.11% | 6.05% | 8.46% | 17.08% | 11.94% | 19.05% |
Accounts Receivable | 1,654 | 1,567 | 1,496 | 1,054 | 843.93 | 720.49 |
Other Receivables | 109.67 | 69.65 | 49.07 | 41.84 | 42.52 | 27.61 |
Receivables | 1,764 | 1,637 | 1,545 | 1,095 | 886.45 | 748.09 |
Inventory | 921.15 | 756.78 | 661.39 | 628.64 | 716.34 | 604.33 |
Prepaid Expenses | - | 1.27 | 5.45 | 0 | 0 | 4.81 |
Other Current Assets | 177.67 | 49.41 | 57.84 | 36.63 | 63.4 | 19.96 |
Total Current Assets | 7,032 | 6,463 | 6,060 | 5,255 | 4,650 | 4,043 |
Property, Plant & Equipment | 1,608 | 1,634 | 1,609 | 1,496 | 1,304 | 1,158 |
Long-Term Investments | 205.55 | 195.07 | 125.31 | 106.77 | 118.61 | 130.41 |
Other Intangible Assets | 301.2 | 249.08 | 232.09 | 190.47 | 111.1 | 95.98 |
Long-Term Deferred Tax Assets | 71.82 | 73.9 | 55.39 | 58.32 | 36.95 | 30.66 |
Long-Term Deferred Charges | 535.08 | 529.03 | 263.61 | 128.03 | 131.88 | 80.51 |
Other Long-Term Assets | 152.3 | 78.98 | 95.2 | 94.05 | 128.51 | 158.09 |
Total Assets | 9,906 | 9,223 | 8,440 | 7,328 | 6,481 | 5,697 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 666.43 | 556.95 | 568.35 | 277.2 | 255.74 | 267.17 |
Accrued Expenses | 0.05 | 313.82 | 180.54 | 296.13 | 297.36 | 53.09 |
Short-Term Debt | - | 30 | 15 | 55 | 30 | 38 |
Current Portion of Leases | 14.27 | 17.79 | 20.18 | 20.86 | 20.63 | 25.01 |
Current Income Taxes Payable | 157.66 | 34.93 | 91.28 | 84.1 | 83.5 | 80.85 |
Current Unearned Revenue | 67.91 | 30.01 | 41.53 | 26.49 | 26.7 | 24.11 |
Other Current Liabilities | 143.02 | 108.73 | 149.37 | 54.26 | 80.02 | 193.72 |
Total Current Liabilities | 1,049 | 1,092 | 1,066 | 814.03 | 793.94 | 681.96 |
Long-Term Debt | 0.23 | 0.23 | 0.23 | 0.23 | 0.23 | 0.23 |
Long-Term Leases | 12.95 | 19.69 | 33.87 | 35.56 | 41.91 | 47.67 |
Long-Term Unearned Revenue | 49.63 | 49.63 | 41.41 | 53.87 | 58.05 | 63.6 |
Long-Term Deferred Tax Liabilities | 0.32 | - | 0.11 | 1.46 | 3.3 | - |
Other Long-Term Liabilities | 24.37 | 33.54 | 24.64 | 12.95 | - | - |
Total Liabilities | 1,137 | 1,195 | 1,166 | 918.09 | 897.43 | 793.45 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 1,013 | 1,016 | 1,016 | 1,008 | 1,008 | 1,008 |
Additional Paid-In Capital | 253.85 | 281.3 | 244.18 | 102.99 | 119.41 | 119.41 |
Retained Earnings | 7,569 | 6,829 | 6,138 | 5,317 | 4,481 | 3,783 |
Treasury Stock | -35.9 | -68.3 | -98.86 | - | - | - |
Comprehensive Income & Other | -1.11 | -1.11 | 0.87 | 6.75 | 13.1 | 10.95 |
Total Common Equity | 8,799 | 8,057 | 7,300 | 6,434 | 5,622 | 4,921 |
Minority Interest | -29.62 | -29.24 | -26.81 | -24.03 | -37.79 | -16.96 |
Shareholders' Equity | 8,770 | 8,028 | 7,274 | 6,410 | 5,584 | 4,904 |
Total Liabilities & Equity | 9,906 | 9,223 | 8,440 | 7,328 | 6,481 | 5,697 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 27.45 | 67.72 | 69.27 | 111.64 | 92.77 | 110.91 |
Net Cash (Debt) | 4,142 | 3,951 | 3,720 | 3,382 | 2,891 | 2,555 |
Net Cash Growth | 5.66% | 6.20% | 9.99% | 16.98% | 13.16% | 16.08% |
Net Cash Per Share | 4.14 | 3.92 | 3.68 | 3.36 | 2.86 | 2.53 |
Filing Date Shares Outstanding | 1,013 | 1,016 | 1,016 | 1,008 | 1,008 | 1,008 |
Total Common Shares Outstanding | 1,013 | 1,016 | 1,016 | 1,008 | 1,008 | 1,008 |
Working Capital | 5,983 | 5,371 | 4,993 | 4,441 | 3,856 | 3,361 |
Book Value Per Share | 8.69 | 7.93 | 7.18 | 6.39 | 5.58 | 4.88 |
Tangible Book Value | 8,498 | 7,808 | 7,068 | 6,244 | 5,510 | 4,825 |
Tangible Book Value Per Share | 8.39 | 7.69 | 6.96 | 6.20 | 5.47 | 4.79 |
Buildings | - | 657.02 | 613.6 | 599.08 | 593.38 | 569.55 |
Machinery | - | 1,597 | 1,546 | 1,341 | 1,251 | 1,088 |
Construction In Progress | - | 365.94 | 309.38 | 293.76 | 92.07 | 17.21 |